Montreal’s AI Labs Go Wet, Biotech Gets an Upgrade

Montreal’s AI scene is moving from pure algorithms to lab benches, fusing machine learning with biotech and automated testing. Here is how design-make-test loops, agent workflows, and hospital ties are reshaping Canadian drug discovery and tools.

In Montreal’s Mile End, the glow of Jupyter notebooks now competes with the cool fluorescence of incubators. The city’s artificial intelligence community, long known for elegant models and benchmark papers, is taking its code to the bench. Teams are wiring up design-make-test loops, using AI to propose molecules or protein tweaks, then validating them with automated assays, cloud labs, or partner facilities. What began as clever chemistry models is turning into a hands-on biotech push, and it is changing the texture of the local tech scene. What is happening: a generation of researchers from Mila, McGill, and Université de Montréal are teaming with life-science veterans to build end-to-end discovery pipelines. Why now: cheaper lab automation, a rising toolkit for generative biology, and a wave of pharma partnerships. Where: concentrated in Montreal’s research corridors and startup studios, with spillover to affiliated hospitals and contract labs across Quebec. When: momentum built over the past year, as companies shifted focus from static datasets to closed-loop experimentation. How: agents coordinate everything from hypothesis generation to instrument scheduling, then learn from t